These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 5830976)

  • 41. Influence of factor IX on overall plasma coagulability and fibrinolytic potential as measured by global assay: monitoring in haemophilia B.
    Goldenberg NA; Bombardier C; Hathaway WE; McFarland K; Jacobson L; Manco-Johnson MJ
    Haemophilia; 2008 Jan; 14(1):68-77. PubMed ID: 18005147
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Electrocardiographic changes in progressive muscular dystrophy].
    Slucka C; Hausmanowa-Petrusewicz I
    Neurol Neurochir Psychiatr Pol; 1965; 15(5):685-90. PubMed ID: 5861421
    [No Abstract]   [Full Text] [Related]  

  • 43. Fibrinolytic activity and recalcified plasma clotting time in uremia.
    Bector NP; Gupta RK; Pahuja JK
    J Assoc Physicians India; 1971 Sep; 19(9):615-8. PubMed ID: 5162126
    [No Abstract]   [Full Text] [Related]  

  • 44. Analysis of the QRS vector loop in muscular dystrophy.
    Vallbona C; Bagby GC; Woodfin WS; Gilliam J; Carter RE
    Cardiovasc Res Cent Bull; 1966; 5(1):8-15. PubMed ID: 5338793
    [No Abstract]   [Full Text] [Related]  

  • 45. [Value of the test with Nakom for assessing the state of the sympathoadrenal system in patients with different forms of progressive muscular dystrophy].
    Badalian LO; Amanova ZN; Temin PA
    Lab Delo; 1984; (11):649-52. PubMed ID: 6084734
    [No Abstract]   [Full Text] [Related]  

  • 46. [Regulation of fibrinolysis and anti-fibrinolytic activity of the serum in children].
    Alekseenko IF
    Sov Zdravookhr Kirg; 1969; 6():18-22. PubMed ID: 5375017
    [No Abstract]   [Full Text] [Related]  

  • 47. [Fibrinolytic activity of urine in proteinuria].
    Lausch A; Thiele G
    Z Gesamte Inn Med; 1971 Oct; 26(20):662-4. PubMed ID: 5211691
    [No Abstract]   [Full Text] [Related]  

  • 48. [The circulatory system in children suffering from progressive muscular dystrophy].
    Skierska A; Rokicki W
    Wiad Lek; 2001; 54(3-4):208-14. PubMed ID: 11436688
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Behavior of the intrinsic fibrinolytic system in healthy blood donors].
    Huyke R; Vogel G; Kulle M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):484-91. PubMed ID: 6083915
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Serum fibrinolytic activity and recalcified plasma clotting time in ischaemic heart disease.
    Arora A; Gupta JC; Arora MM
    J Indian Med Assoc; 1969 Nov; 53(10):477-82. PubMed ID: 5368384
    [No Abstract]   [Full Text] [Related]  

  • 51. [Coagulation and the fibrinolytic blood system in surgical patients with various lung and pleural diseases].
    Onushchenko BN; Kolesnikov IS; Pleshakov VT; Vikhriev BS; Sokolov SN; Klur BIu; Shcherba BV; Solov'eva OV
    Vestn Khir Im I I Grek; 1966 May; 96(5):51-4. PubMed ID: 6001202
    [No Abstract]   [Full Text] [Related]  

  • 52. Evoked muscle action potentials in patients with muscular dystrophy.
    López-Estrada E; López E
    Arch Phys Med Rehabil; 1984 Nov; 65(11):717-20. PubMed ID: 6093734
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Duchenne muscular dystrophy and anesthesia. A retrospective study].
    Petersen CT; Nørregaard FO
    Ugeskr Laeger; 1996 Oct; 158(44):6274-6. PubMed ID: 8966812
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Muscular dystrophy.
    Brown JC
    Practitioner; 1982 Jun; 226(1368):1031-6. PubMed ID: 7111135
    [No Abstract]   [Full Text] [Related]  

  • 55. [Studies on the fibrinolytic potential in mature newborn and young infants].
    Brüster H; Pfitzner W
    Monatsschr Kinderheilkd (1902); 1965 Jul; 113(7):476-81. PubMed ID: 5832826
    [No Abstract]   [Full Text] [Related]  

  • 56. Long-term electrocardiographic studies in patients with Duchenne progressive muscular dystrophy.
    Lukasik E; Liszewska-Pfejfer D; Rubach K; Szwed H
    Acta Med Pol; 1980; 21(2):181-91. PubMed ID: 7211467
    [No Abstract]   [Full Text] [Related]  

  • 57. A multiparameter test of clot formation and fibrinolysis for in-vitro drug screening.
    Kostka B; Para J; Sikora J
    Blood Coagul Fibrinolysis; 2007 Oct; 18(7):611-8. PubMed ID: 17890947
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Differential diagnosis of Becker and Duchenne muscular dystrophy].
    Alvarez Leal M; Hernández Sifuentes PM; Pérez-Zuno JA
    Gac Med Mex; 1994; 130(6):454-8. PubMed ID: 7557060
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [On the physiology of blood coagulation and fibrinolysis as the basic principles in the clinical use of anticoagulants, thrombolytics and inhibitors of fibrinolysis].
    Van de Loo J
    Rev Colomb Obstet Ginecol; 1967; 18(5):321-6. PubMed ID: 5612568
    [No Abstract]   [Full Text] [Related]  

  • 60. [The importance of fibrinolysis in the pathogenesis of glomerular inflammation].
    Maggiore Q
    Minerva Nefrol; 1968; 15(3):195-209. PubMed ID: 5706240
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.